{"DataElement":{"publicId":"3952848","version":"1","preferredName":"Thymoma Masaoka Stage","preferredDefinition":"Extent of the thymoma tumor using the Masaoka Staging system.","longName":"3952788v1.0:3952832v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3952788","version":"1","preferredName":"Thymoma Masaoka Stage","preferredDefinition":"A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant and probably not neoplastic. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (Stedman, 25th ed)_A staging system for thymoma based on the anatomic extent of disease at the time of surgery.","longName":"3952785v1.0:3952786v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3952785","version":"1","preferredName":"Thymoma","preferredDefinition":"A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant and probably not neoplastic. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (Stedman, 25th ed)","longName":"C3411","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thymoma","conceptCode":"C3411","definition":"A neoplasm arising from the epithelial cells of the thymus.  Although thymomas are usually encapsulated tumors, they may invade the capsule and infiltrate the surrounding tissues or even metastasize to distant anatomic sites.  The following morphologic subtypes are currently recognized: type A, type B, type AB, metaplastic, micronodular, microscopic, and sclerosing thymoma.  Thymomas type B are further subdivided into types B1, B2, and B3. Thymoma type B3 usually has the most aggressive clinical course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-804E-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3952786","version":"1","preferredName":"Masaoka Staging System","preferredDefinition":"A staging system for thymoma based on the anatomic extent of disease at the time of surgery.","longName":"C112006","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thymoma by Masaoka-Koga Stage","conceptCode":"C112006","definition":"A staging system for thymoma based on the anatomic extent of disease at the time of surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-805E-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-806F-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for Thymoma enrollment form per request by T.Lichtenberg. mc 11/15/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3952832","version":"1","preferredName":"Masaoka Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3952832v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"I","valueDescription":"Masaoka Stage I","ValueMeaning":{"publicId":"3952833","version":"1","preferredName":"Masaoka Stage I","longName":"3952833","preferredDefinition":"The tumor is completely encapsulated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Masaoka-Koga Stage I","conceptCode":"C112007","definition":"The tumor is completely encapsulated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-80E2-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB3D0430-80FB-BE47-E040-BB89AD431323","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","deletedIndicator":"No"},{"value":"IIa","valueDescription":"Masaoka Stage IIa","ValueMeaning":{"publicId":"3952834","version":"1","preferredName":"Masaoka Stage IIa","longName":"3952834","preferredDefinition":"The tumor shows microscopic invasion into the capsule.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Masaoka-Koga Stage IIa","conceptCode":"C112008","definition":"The tumor shows microscopic invasion into the capsule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-8107-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB3D0430-8120-BE47-E040-BB89AD431323","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","deletedIndicator":"No"},{"value":"IIb","valueDescription":"Masaoka Stage IIb","ValueMeaning":{"publicId":"3952835","version":"1","preferredName":"Masaoka Stage IIb","longName":"3952835","preferredDefinition":"The tumor shows invasion through the capsule and into the surrounding fatty tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Masaoka-Koga Stage IIb","conceptCode":"C112009","definition":"The tumor shows invasion through the capsule and into the surrounding fatty tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-812C-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB3D0430-8145-BE47-E040-BB89AD431323","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","deletedIndicator":"No"},{"value":"III","valueDescription":"Masaoka Stage III","ValueMeaning":{"publicId":"3952836","version":"1","preferredName":"Masaoka Stage III","longName":"3952836","preferredDefinition":"The tumor shows invasion into the neighboring tissues and organs of the lower neck or upper chest.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Masaoka-Koga Stage III","conceptCode":"C112010","definition":"The tumor shows invasion into the neighboring tissues and organs of the lower neck or upper chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-8151-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB3D0430-816A-BE47-E040-BB89AD431323","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","deletedIndicator":"No"},{"value":"IVa","valueDescription":"Masaoka Stage Iva","ValueMeaning":{"publicId":"3952837","version":"1","preferredName":"Masaoka Stage Iva","longName":"3952837","preferredDefinition":"The tumor shows metastasis throughout the pleural and/or pericardial spaces.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Masaoka-Koga Stage IVa","conceptCode":"C112011","definition":"The tumor shows metastasis throughout the pleural and/or pericardial spaces.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-8176-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB3D0430-818F-BE47-E040-BB89AD431323","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","deletedIndicator":"No"},{"value":"IVb","valueDescription":"Masaoka Stage IVb","ValueMeaning":{"publicId":"3952838","version":"1","preferredName":"Masaoka Stage IVb","longName":"3952838","preferredDefinition":"The tumor shows lymphogenous or hematogenous metastasis to distant sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Masaoka-Koga Stage IVb","conceptCode":"C112012","definition":"The tumor shows lymphogenous or hematogenous metastasis to distant sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-819B-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB3D0430-81B4-BE47-E040-BB89AD431323","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-80CB-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"COOPERM","dateModified":"2017-02-08","changeDescription":"Created for Thymoma enrollment form per request by T.Lichtenberg. mc 11/15/13  Added min/max length for C3D. mc 2/8/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[{"name":"THYM_MASAOKA_STG","type":"C3D Name","context":"CCR"},{"name":"CCR","type":"USED_BY","context":"CCR"}],"ReferenceDocuments":[{"name":"Masaoka Staging","type":"Preferred Question Text","description":"Masaoka Staging","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3DA9F5-1323-7BEF-E040-BB89AD433FB2","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"TSESU","dateModified":"2018-07-16","changeDescription":"Created for Thymoma enrollment form per request by T.Lichtenberg. mc 11/15/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}